Compare BEEM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEEM | HBIO |
|---|---|---|
| Founded | 2006 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 26.5M |
| IPO Year | 2018 | 2000 |
| Metric | BEEM | HBIO |
|---|---|---|
| Price | $1.41 | $8.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $3.50 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.5M | 21.2K |
| Earning Date | 04-09-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $28,236,000.00 | ★ $116,176,000.00 |
| Revenue This Year | $40.48 | $4.77 |
| Revenue Next Year | $32.17 | $8.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.97 | $0.38 |
| 52 Week High | $4.04 | $8.40 |
| Indicator | BEEM | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 70.00 |
| Support Level | $1.38 | $5.91 |
| Resistance Level | $1.42 | N/A |
| Average True Range (ATR) | 0.13 | 0.31 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 23.91 | 75.57 |
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.